InsidersTradesSigma
Browse the complete record of transactions filed by Fontenot Jason D., Vice-Président, Directeur Scientifique. Officer active across 1 companies, notably Sangamo Therapeutics, INC. Cumulatively, 2 reports have been published. The latest transaction was disclosed on 25 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Jason D. Fontenot is the SVP and Chief Scientific Officer at SANGAMO THERAPEUTICS, INC. He is responsible for leading scientific initiatives and research within the company. His role is essential for ensuring innovation and the development of new products.